Assessing the Effects of Educational Training Aimed to Improve Pain-reporting Reliability in Children After Surgery
12 de marzo de 2020 actualizado por: University of Haifa
Treating pain, just as treating other medical conditions, depends on accurate assessment of patient's condition. When assessing pain, as other subjective symptoms, the challenge is twofold because the assessment is dependent on patient's understanding and use of the scale, all the more so in children
So far, attempts to improve pain assessments have been focused on the development and refining pain scales. No emphasis has been placed on improving patient's ability to report their pain. Our purpose is to evaluate a training program designed to improve the quality of children's post-surgical pain intensity reports.
After receiving Helsinki approval, eligible children and their parents will signed informed-consent. After surgery, the children, their parents, and the department nurses will assess children's pain intensity. Immediately after the nurse assessment, parents will assess their child's pain (blindly and independently) and the children will report their pain on four different pain scales.
Children aged 8-17, hospitalized in Rambam medical-center for elective surgery will be invited to participate. Children in the experimental group will be exposed to a training program, developed for this study, aimed to teach and train how to report pain. The control group will receive the standard pre-surgical instructions.
Descripción general del estudio
Estado
Terminado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Intervencionista
Inscripción (Actual)
98
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
-
Haifa, Israel, 3498838
- University of Haifa, The Clinical Pain Innovation Lab
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
8 años a 17 años (Niño)
Acepta Voluntarios Saludables
No
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
- children at age 8-17 years;
- absence of psychiatry, cognitive, and/or neurological disorders;
- understand the purpose and the instructions of the study, agree to participate and parent signed inform consent.
Exclusion Criteria:
1. children suffering from Post traumatic stress disorder.
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Interventional arm
The intervention, which was aimed to educate children on how to use pain scales and provide reliable pain assessments was based on a two short animation clips, lasting approximately 5 min each, and a short (5 min) guided interaction between the study nurse and the participants, in between the two clips.
|
The first animation clip focuses on the importance of pain assessment introduce three pain scales (categorical, NPS and faces) followed by explanations on their properties and on the appropriate way to use them.The second movie was aimed to provide an opportunity to implement the new knowledge in case studies
|
|
Otro: Control
Children underwent the routine pre-operative preparations, which included a section on pain assessment.
|
Routine preoperative preparations, which included a section on pain assessment instructions.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Quality of pain intensity scores based on the concordance between pain reports on different scales.
Periodo de tiempo: Pain intensity rating before analgesic consumption.
|
The average difference between scores reported on the different scales was calculated as follows: The difference between to pain scores reported on each possible pairs of two scales was calculated in absolute values.
The average difference of the 6 pairs was calculated.
The 5-point CAT was transformed into a 0-10 scale by multiplying its values by 2.5.
|
Pain intensity rating before analgesic consumption.
|
|
Quality of pain intensity scores based on the concordance between pain reports on different scales.
Periodo de tiempo: Pain intensity rating one hour after analgesic consumption.
|
The average difference between scores reported on the different scales was calculated as follows: The difference between to pain scores reported on each possible pairs of two scales was calculated in absolute values.
The average difference of the 6 pairs was calculated.
The 5-point CAT was transformed into a 0-10 scale by multiplying its values by 2.5.
|
Pain intensity rating one hour after analgesic consumption.
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
The difference between children assessment vs. nurses assessment.
Periodo de tiempo: NPS ratings before and one hour after analgesic consumption
|
The difference between children pain assessment vs. nurses assessment on a 0-10 numerical pain scale (NPS), in which 0 indicates "no pain" and 10 "the worst pain imaginable."
|
NPS ratings before and one hour after analgesic consumption
|
|
The average difference between children assessment vs. parents.
Periodo de tiempo: NPS ratings before and one hour after analgesic consumption
|
The difference between children pain assessment vs. parents assessment on a 0-10 numerical pain scale (NPS), in which 0 indicates "no pain" and 10 "the worst pain imaginable."
|
NPS ratings before and one hour after analgesic consumption
|
|
The average decrease in pain following analgesia: NPS
Periodo de tiempo: NPS ratings before and one hour after analgesic consumption
|
The average decrease in pain following analgesic consumption (Delta NPS) based on a 0-10 numerical pain scale (NPS), in which 0 indicates "no pain" and 10 "the worst pain imaginable."
|
NPS ratings before and one hour after analgesic consumption
|
|
Quality of pain intensity scores based on the concordance between pain reports on different scales.
Periodo de tiempo: Pain intensity ratings before analgesic consumption.
|
The within-subjects standard deviation (SD) between the 4 pain scores (provided at the same time of assessment).
To assure that variability will be appropriately reflected by this measure, subjects who reported only "0" or only "10" in all 4 scales were excluded from this analysis due to potential bias of the within-subjects SD due to floor or ceiling effects.
|
Pain intensity ratings before analgesic consumption.
|
|
Quality of pain intensity scores based on the concordance between pain reports on different scales.
Periodo de tiempo: Pain intensity ratings one hour after analgesic consumption.
|
The within-subjects standard deviation (SD) between the 4 pain scores (provided at the same time of assessment).
To assure that variability will be appropriately reflected by this measure, subjects who reported only "0" or only "10" in all 4 scales were excluded from this analysis due to potential bias of the within-subjects SD due to floor or ceiling effects.
|
Pain intensity ratings one hour after analgesic consumption.
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Colaboradores
Publicaciones y enlaces útiles
La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
20 de junio de 2019
Finalización primaria (Actual)
20 de noviembre de 2019
Finalización del estudio (Actual)
21 de noviembre de 2019
Fechas de registro del estudio
Enviado por primera vez
8 de marzo de 2020
Primero enviado que cumplió con los criterios de control de calidad
12 de marzo de 2020
Publicado por primera vez (Actual)
13 de marzo de 2020
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
13 de marzo de 2020
Última actualización enviada que cumplió con los criterios de control de calidad
12 de marzo de 2020
Última verificación
1 de marzo de 2020
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- 0091-19-RMB
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
No
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
producto fabricado y exportado desde los EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .